Literature DB >> 11568638

Differential in vivo internalization of MOR-1 and MOR-1C by morphine.

C Abbadie1, G W Pasternak.   

Abstract

The mu opioid receptor MOR-1 is internalized by many mu agonists, but not morphine. To see whether differences in the intracellular carboxy terminus influences internalization, we examined internalization of a splice variant of the mu opioid receptor, MOR-1C, in the lateral septum of the mouse in vivo. Following intracerebroventricular (i.c.v.) saline treatment, MOR-1C-like immunoreactivity (LI) within neurons in naive mice was found predominantly in clusters close to the plasma membrane. Following either intracerebroventricular [d-Ala2, MePhe4,Gly(ol)5]enkephalin (DAMGO) or morphine, MOR-1C-LI clustered into endosomes in the cytoplasm. This effect was suppressed by prior administration of the opioid antagonist naloxone. In contrast, only DAMGO, and not morphine, internalized MOR-1-LI. These results illustrate differences in internalization between two MOR-1 variants that have alternative splicing at the COOH terminus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568638     DOI: 10.1097/00001756-200110080-00017

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  27 in total

1.  Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene.

Authors:  Y X Pan; J Xu; L Mahurter; E Bolan; M Xu; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Promoting science in a pragmatic world: not (yet) time for partial opioid rotation.

Authors:  Florian Strasser
Journal:  Support Care Cancer       Date:  2005-07-12       Impact factor: 3.603

3.  Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.

Authors:  Jin Xu; Ming Xu; Taylor Brown; Grace C Rossi; Yasmin L Hurd; Charles E Inturrisi; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

Review 4.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

5.  Mu-opioid receptor splice variants: sex-dependent regulation by chronic morphine.

Authors:  Vittorio Verzillo; Priyanka A Madia; Nai-Jiang Liu; Sumita Chakrabarti; Alan R Gintzler
Journal:  J Neurochem       Date:  2014-06-11       Impact factor: 5.372

6.  Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neurochem       Date:  2019-10-20       Impact factor: 5.372

Review 7.  Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system.

Authors:  Patrick M Regan; Rajnish S Dave; Prasun K Datta; Kamel Khalili
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

8.  Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization.

Authors:  S Puig; K E Barker; S R Szott; P T Kann; J S Morris; H B Gutstein
Journal:  Mol Pharmacol       Date:  2020-07-28       Impact factor: 4.436

9.  Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence.

Authors:  Joseph A Kim; Selena Bartlett; Li He; Carsten K Nielsen; Amy M Chang; Viktor Kharazia; Maria Waldhoer; Chrissi J Ou; Stacy Taylor; Madeline Ferwerda; Dragana Cado; Jennifer L Whistler
Journal:  Curr Biol       Date:  2008-01-22       Impact factor: 10.834

10.  Epitope-tagged receptor knock-in mice reveal that differential desensitization of alpha2-adrenergic responses is because of ligand-selective internalization.

Authors:  Roujian Lu; Yong Li; Youwen Zhang; Yunjia Chen; Angela D Shields; Danny G Winder; Timothy Angelotti; Kai Jiao; Lee E Limbird; Yi Zhou; Qin Wang
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.